Miñano F J, Vizcaino M, Myers R D
Department of Pharmacology, School of Medicine, East Carolina University, Greenville, NC 27858.
Pharmacol Biochem Behav. 1991 Jun;39(2):535-9. doi: 10.1016/0091-3057(91)90223-o.
This investigation examined the extent to which the activity of a prostaglandin (PG) in the anterior hypothalamic, preoptic area (AH/POA) of the rat plays a role in the intense fever induced by macrophage inflammatory protein-1 (MIP-1) applied directly to this anatomical region. For the microinjection of both a PG synthesis inhibitor, indomethacin, and MIP-1 into sites within the AH/POA, guide cannulae were implanted chronically just above this pyrogen-reactive region. Postoperatively, the body temperature (Tb) of each rat was monitored in the unrestrained condition by means of a colonic thermistor probe. MIP-1 microinjected into the AH/POA in a 0.5-microliter volume evoked a biphasic fever when given in a dose of 5.6 picograms (pg) and a monophasic fever in a dose of 28 pg. The latency of the febrile response was ordinarily 15 min with an asymptote of 1.5 degrees C reached ordinarily within 2.0-2.5 h. When the cytokine-reactive site in the AH/POA was pretreated with indomethacin microinjected in an efficacious dose of 0.5 microgram, the MIP-1 fever evoked by 5.6 pg was not inhibited. Further, pretreatment of AH/POA sites with indomethacin prior to the higher 28-pg dose of MIP-1 delayed the febrile response but did not block it. As a systemic control, indomethacin also was administered intraperitoneally in a dose of 5.0 mg/kg, again 15 min prior to the microinjection of MIP-1 into the AH/POA. In this case, indomethacin only partially attenuated but did not block the fever evoked by either dose of MIP-1.(ABSTRACT TRUNCATED AT 250 WORDS)
本研究考察了前列腺素(PG)在大鼠下丘脑前部视前区(AH/POA)的活性在直接注射巨噬细胞炎性蛋白-1(MIP-1)至该解剖区域所诱导的高热中发挥作用的程度。为了将PG合成抑制剂吲哚美辛和MIP-1微量注射至AH/POA内的位点,将引导套管长期植入该致热反应区域上方。术后,通过结肠热敏电阻探头在无束缚状态下监测每只大鼠的体温(Tb)。以0.5微升体积将MIP-1微量注射至AH/POA,剂量为5.6皮克(pg)时诱发双相热,剂量为28 pg时诱发单相热。发热反应的潜伏期通常为15分钟,通常在2.0 - 2.5小时内达到1.5摄氏度的峰值。当以0.5微克有效剂量微量注射吲哚美辛预处理AH/POA中的细胞因子反应位点时,5.6 pg的MIP-1所诱发的发热未被抑制。此外,在给予较高剂量28 pg的MIP-1之前用吲哚美辛预处理AH/POA位点会延迟发热反应,但不会阻断该反应。作为全身对照,同样在将MIP-1微量注射至AH/POA前15分钟腹腔注射5.0毫克/千克剂量的吲哚美辛。在这种情况下,吲哚美辛仅部分减弱但未阻断任一剂量MIP-1所诱发的发热。(摘要截断于250字)